Metabolite alterations in autistic children: a 1H MR spectroscopy study

Area of Science:

• Neuroscience
• Biochemistry
• Pediatrics

Background:

• Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition.
• Understanding the underlying brain metabolism in ASD is crucial for diagnosis and treatment.
• Proton magnetic resonance spectroscopy (1H MRS) is a non-invasive neuroimaging technique.

Purpose of the Study:

• To evaluate the utility of 1H MRS in detecting cerebral metabolite alterations in children with autism.
• To compare metabolite levels between autistic children and healthy controls.

Main Methods:

• A study group of 12 autistic children (aged 8-15) and 16 healthy controls (aged 7-17) were recruited.
• 1H MRS was performed using a single-voxel method, focusing on the frontal lobe regions.
• Diagnosis of autism was confirmed using ICD-10 criteria.

Main Results:

• Autistic children exhibited significantly lower ratios of N-acetylaspartate/creatine (NAA/Cr), γ-aminobutyric acid/creatine (GABA/Cr), and glutamate/creatine (Glx/Cr) in the frontal lobes compared to controls.
• An increased myoinositol/creatine (mI/Cr) ratio was observed in autistic children.
• No significant differences in choline/creatine (Cho/Cr) ratios or between hemispheres were found.

Conclusions:

• 1H MRS can provide valuable insights into abnormal brain metabolism associated with autism.
• Observed alterations in NAA/Cr, GABA/Cr, Glx/Cr, and mI/Cr may contribute to the pathogenesis of ASD.
• Further research is warranted to explore the clinical implications of these metabolic changes.